M. S. Greenblatt, W. P. Bennett, M. Hollstein, and C. C. Harris, Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis, Cancer Res, vol.54, pp.4855-4878, 1994.

T. Soussi, Advances in carcinogenesis: A historical perspective from observational studies to tumor genome sequencing and TP53 mutation spectrum analysis, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, vol.1816, issue.2, pp.1816-199, 2011.
DOI : 10.1016/j.bbcan.2011.07.003

T. Soussi, TP53 Mutations in Human Cancer: Database Reassessment and Prospects for the Next Decade, Adv. Cancer Res, vol.110, pp.107-139, 2011.
DOI : 10.1016/B978-0-12-386469-7.00005-0

C. J. Brown, S. Lain, C. S. Verma, A. R. Fersht, and D. P. Lane, Awakening guardian angels: drugging the p53 pathway, Nature Reviews Cancer, vol.74, issue.12, pp.862-873, 2009.
DOI : 10.1038/bjc.1996.415

C. Caron-de-fromentel and T. Soussi, TP53 tumor suppressor gene: A model for investigating human mutagenesis, Genes, Chromosomes and Cancer, vol.6, issue.1, pp.1-15, 1992.
DOI : 10.1128/MCB.10.10.5502

N. F. Cariello, C. Beroud, and T. Soussi, Database and software for the analysis of mutations at the human p53 gene, Nucleic Acids Res, vol.22, pp.3549-3550, 1994.

C. Beroud, F. Verdier, and T. Soussi, p53 gene mutation: software and database, Nucleic Acids Research, vol.24, issue.1, pp.147-150, 1996.
DOI : 10.1093/nar/24.1.147
URL : https://academic.oup.com/nar/article-pdf/24/1/147/6962803/24-1-147.pdf

C. Beroud and T. Soussi, p53 and APC gene mutations: software and databases, Nucleic Acids Research, vol.25, issue.1, p.138, 1997.
DOI : 10.1093/nar/25.1.138
URL : https://academic.oup.com/nar/article-pdf/25/1/138/3786555/25-1-138.pdf

T. Soussi, K. Dehouche, and C. Beroud, p53 website and analysis of p53 gene mutations in human cancer: forging a link D968 Nucleic Acids Research Database issue between epidemiology and carcinogenesis, Hum. Mutat, vol.2013, issue.15, pp.105-113, 2000.

C. Beroud and T. Soussi, The UMD-p53 database: New mutations and analysis tools, Human Mutation, vol.18, issue.Suppl, pp.176-181, 2003.
DOI : 10.1097/00004347-199901000-00005

D. Hamroun, S. Kato, C. Ishioka, M. Claustres, C. Beroud et al., The UMD TP53 database and website: update and revisions, Human Mutation, vol.96, issue.1, pp.14-20, 2006.
DOI : 10.1128/MCB.16.9.4961
URL : https://hal.archives-ouvertes.fr/hal-00018577

C. Beroud and T. Soussi, p53 gene mutation: software and database, Nucleic Acids Research, vol.26, issue.1, pp.200-204, 1998.
DOI : 10.1093/nar/26.1.200
URL : https://academic.oup.com/nar/article-pdf/24/1/147/6962803/24-1-147.pdf

K. Edlund, O. Larsson, A. Ameur, I. Bunikis, U. Gyllensten et al., Data-driven unbiased curation of the TP53 tumor suppressor gene mutation database and validation by ultradeep sequencing of human tumors, Proc. Natl Acad. Sci. USA, pp.9551-9556, 2012.
DOI : 10.4161/cbt.5.4.2552
URL : https://hal.archives-ouvertes.fr/hal-01188067

S. E. Kern and J. M. Winter, Elegance, silence and nonsense in the mutations literature for solid tumors, Cancer Biology & Therapy, vol.5, issue.4, pp.349-359, 2006.
DOI : 10.4161/cbt.5.4.2551

N. Quach, M. F. Goodman, and D. Shibata, In vitro mutation artifacts after formalin fixation and error prone translesion synthesis during PCR, BMC Clinical Pathology, vol.155, issue.1, 2004.
DOI : 10.1016/S0002-9440(10)65461-2

T. Soussi and C. Beroud, Assessing TP53 status in human tumours to evaluate clinical outcome, Nature Reviews Cancer, vol.91, issue.3, pp.233-240, 2001.
DOI : 10.1111/j.1349-7006.2000.tb00931.x

S. Kato, S. Y. Han, W. Liu, K. Otsuka, H. Shibata et al., Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis, Proc. Natl Acad. Sci. USA, pp.8424-8429, 2003.
DOI : 10.1056/NEJM199310283291807

T. Soussi, B. Asselain, D. Hamroun, S. Kato, C. Ishioka et al., Meta-analysis of the p53 Mutation Database for Mutant p53 Biological Activity Reveals a Methodologic Bias in Mutation Detection, Clinical Cancer Research, vol.12, issue.1, pp.62-69, 2006.
DOI : 10.1158/1078-0432.CCR-05-0413
URL : https://hal.archives-ouvertes.fr/hal-00018575

T. Soussi, S. Kato, P. P. Levy, and C. Ishioka, Reassessment of theTP53 mutation database in human disease by data mining with a library ofTP53 missense mutations, Human Mutation, vol.13, issue.1, pp.6-17, 2005.
DOI : 10.1128/MCB.16.9.4961

T. Soussi, C. Ishioka, M. Claustres, and C. Beroud, Locus-specific mutation databases: pitfalls and good practice based on the p53 experience, Nature Reviews Cancer, vol.94, issue.1, pp.83-90, 2006.
DOI : 10.1186/1479-7364-2-1-70
URL : https://hal.archives-ouvertes.fr/hal-00018573

H. Berglind, Y. Pawitan, S. Kato, C. Ishioka, and T. Soussi, Analysis of p53 mutation status in human cancer cell lines: a paradigm for cell line cross-contamination, Cancer Biology & Therapy, vol.7, issue.5, pp.699-708, 2008.
DOI : 10.4161/cbt.7.5.5712

O. N. Ikediobi, H. Davies, G. Bignell, S. Edkins, C. Stevens et al., Mutation analysis of 24 known cancer genes in the NCI-60 cell line set Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion, Mol. Cancer Ther. den Dunnen,J.T. and Antonarakis,S.E. Hum. Mutat, vol.5, issue.15, pp.2606-2612, 2000.

S. L. Harris and A. J. Levine, The p53 pathway: positive and negative feedback loops, Oncogene, vol.12, issue.17, pp.2899-2908, 2005.
DOI : 10.1128/MCB.12.12.5581

A. J. Levine, Introduction: The Changing Directions of p53 Research, Genes & Cancer, vol.2, issue.4, pp.382-384, 2011.
DOI : 10.1177/1947601911413463

D. Lane and A. Levine, p53 Research: The Past Thirty Years and the Next Thirty Years, Cold Spring Harbor Perspectives in Biology, vol.2, issue.12, p.893, 2010.
DOI : 10.1101/cshperspect.a000893
URL : http://cshperspectives.cshlp.org/content/2/12/a000893.full.pdf

P. Monti, Y. Ciribilli, J. Jordan, P. Menichini, D. M. Umbach et al., Transcriptional Functionality of Germ Line p53 Mutants Influences Cancer Phenotype, Clinical Cancer Research, vol.13, issue.13, pp.3789-3795, 2007.
DOI : 10.1158/1078-0432.CCR-06-2545

M. Oren and V. Rotter, Mutant p53 Gain-of-Function in Cancer, Cold Spring Harbor Perspectives in Biology, vol.2, issue.2, p.1107, 2010.
DOI : 10.1101/cshperspect.a001107

A. I. Robles and C. C. Harris, Clinical Outcomes and Correlates of TP53 Mutations and Cancer, Cold Spring Harbor Perspectives in Biology, vol.2, issue.3, p.1016, 2010.
DOI : 10.1101/cshperspect.a001016
URL : http://cshperspectives.cshlp.org/content/2/3/a001016.full.pdf

X. Yu, A. Vazquez, A. J. Levine, and D. R. Carpizo, Allele-Specific p53 Mutant Reactivation, Cancer Cell, vol.21, issue.5, pp.614-625, 2012.
DOI : 10.1016/j.ccr.2012.03.042
URL : http://doi.org/10.1016/j.ccr.2012.03.042

F. M. Boeckler, A. C. Joerger, G. Jaggi, T. J. Rutherford, D. B. Veprintsev et al., Targeted rescue of a destabilized mutant of p53 by an in silico screened drug, Proc. Natl Acad. Sci. USA, pp.10360-10365, 2008.
DOI : 10.1107/S0021889892009944

P. C. Ng and S. Henikoff, Predicting the Effects of Amino Acid Substitutions on Protein Function, Annual Review of Genomics and Human Genetics, vol.7, issue.1, pp.61-80, 2006.
DOI : 10.1146/annurev.genom.7.080505.115630

J. G. Jackson, V. Pant, Q. Li, L. L. Chang, A. Quintas-cardama et al., p53-Mediated Senescence Impairs the Apoptotic Response to Chemotherapy and Clinical Outcome in Breast Cancer, Cancer Cell, vol.21, issue.6, pp.793-806, 2012.
DOI : 10.1016/j.ccr.2012.04.027

P. De-cremoux, A. V. Salomon, S. Liva, R. Dendale, B. Bouchind-'homme et al., p53 Mutation as a Genetic Trait of Typical Medullary Breast Carcinoma, JNCI Journal of the National Cancer Institute, vol.91, issue.7, pp.641-643, 1999.
DOI : 10.1093/jnci/91.7.641

T. Li, N. Kon, L. Jiang, M. Tan, T. Ludwig et al., Tumor Suppression in the Absence of p53-Mediated Cell-Cycle Arrest, Apoptosis, and Senescence, Cell, vol.149, issue.6, pp.1269-1283, 2012.
DOI : 10.1016/j.cell.2012.04.026

C. A. Brady, D. Jiang, S. S. Mello, T. M. Johnson, L. A. Jarvis et al., Distinct p53 Transcriptional Programs Dictate Acute DNA-Damage Responses and Tumor Suppression, Cell, vol.145, issue.4, pp.571-583, 2011.
DOI : 10.1016/j.cell.2011.03.035
URL : http://doi.org/10.1016/j.cell.2011.03.035

L. Chin, W. C. Hahn, G. Getz, and M. Meyerson, Making sense of cancer genomic data, Genes & Development, vol.25, issue.6, pp.534-555, 2011.
DOI : 10.1101/gad.2017311